SV2009002864A - Inhibidores del vih enzima de integrase - Google Patents

Inhibidores del vih enzima de integrase

Info

Publication number
SV2009002864A
SV2009002864A SV2008002864A SV2008002864A SV2009002864A SV 2009002864 A SV2009002864 A SV 2009002864A SV 2008002864 A SV2008002864 A SV 2008002864A SV 2008002864 A SV2008002864 A SV 2008002864A SV 2009002864 A SV2009002864 A SV 2009002864A
Authority
SV
El Salvador
Prior art keywords
enzym
integrase
hiv inhibitors
inhibitors
hiv
Prior art date
Application number
SV2008002864A
Other languages
English (en)
Inventor
Klaus Ruprecht Dress
Ted William Johnson
Michael Bruno Plewe
Steven Paul Tanis
Huichun Zhu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2009002864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2009002864A publication Critical patent/SV2009002864A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE LA FÓRMULA (l) Y SUS SALES Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES, SU SÍNTESIS, Y SU USO COMO MODULADORES O INHIBIDORES DE LA ENZIMA INGRASA DEL VIRUS DE LA INMUNODEFICIENCIA HUMANO ("VIH")
SV2008002864A 2005-10-07 2008-04-07 Inhibidores del vih enzima de integrase SV2009002864A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20

Publications (1)

Publication Number Publication Date
SV2009002864A true SV2009002864A (es) 2009-02-19

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008002864A SV2009002864A (es) 2005-10-07 2008-04-07 Inhibidores del vih enzima de integrase

Country Status (21)

Country Link
US (1) US20070099915A1 (es)
EP (1) EP1934220A1 (es)
JP (1) JP2009511463A (es)
KR (1) KR20080042171A (es)
AP (1) AP2008004400A0 (es)
AR (1) AR061398A1 (es)
AU (1) AU2006300926A1 (es)
BR (1) BRPI0616657A2 (es)
CA (1) CA2623506A1 (es)
CR (1) CR9859A (es)
EA (1) EA200800758A1 (es)
IL (1) IL189939A0 (es)
MA (1) MA29855B1 (es)
NL (1) NL2000255A1 (es)
NO (1) NO20081230L (es)
PE (1) PE20070494A1 (es)
RS (1) RS20080141A (es)
SV (1) SV2009002864A (es)
TW (1) TW200800219A (es)
UY (1) UY29843A1 (es)
WO (1) WO2007042883A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005103051A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
US5616609A (en) * 1991-08-08 1997-04-01 Ikekawa; Tetsuro Carcinostatic compound and production thereof
WO1995003311A1 (fr) * 1993-07-19 1995-02-02 Xuande Luo Derives de qinghaosu utilises pour lutter contre le sida
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
AU8009900A (en) * 1999-10-13 2001-04-23 Merck & Co., Inc. Hiv integrase inhibitors
WO2001098248A2 (en) * 2000-06-16 2001-12-27 Bristol-Myers Squibb Company Hiv integrase inhibitors
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CA2513141A1 (en) * 2003-01-27 2004-08-12 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
WO2005103051A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
WO2006027694A1 (en) * 2004-09-07 2006-03-16 Pfizer Inc. Inhibitors of the hiv integrase enzyme

Also Published As

Publication number Publication date
US20070099915A1 (en) 2007-05-03
TW200800219A (en) 2008-01-01
IL189939A0 (en) 2008-08-07
EA200800758A1 (ru) 2008-08-29
EP1934220A1 (en) 2008-06-25
MA29855B1 (fr) 2008-10-03
BRPI0616657A2 (pt) 2011-06-28
CR9859A (es) 2008-06-20
RS20080141A (en) 2009-07-15
JP2009511463A (ja) 2009-03-19
NL2000255A1 (nl) 2007-04-11
NO20081230L (no) 2008-04-08
AU2006300926A1 (en) 2007-04-19
WO2007042883A1 (en) 2007-04-19
AP2008004400A0 (en) 2008-04-30
AR061398A1 (es) 2008-08-27
CA2623506A1 (en) 2007-04-19
KR20080042171A (ko) 2008-05-14
UY29843A1 (es) 2007-05-31
PE20070494A1 (es) 2007-06-13

Similar Documents

Publication Publication Date Title
BRPI0510319A (pt) inibidores da enzima integrase de hiv
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
HN2007000267A (es) Compuestos de 4-metil piridopirimidinoma
UY30426A1 (es) Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones.
ECSP099476A (es) Compuestos carboxamida y su uso como inhibidores de calpaína
CR10149A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
CL2011001658A1 (es) Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor.
CO6741203A2 (es) Derivados de biciclo[3,2,1]octilamida y sus usos
MA33275B1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
NI200900040A (es) Derivados de quinazolinona 5-substituidos como agentes antitumorales.
DOP2013000016A (es) Formas cristalinas del dimetoxi-docetaxel y sus procedimientos de preparacion
NI201000005A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico.
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
PE20121524A1 (es) Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
AR052357A1 (es) Pirazolo piridinas sustituidas moduladoras de la actividad de quinasas
MA28519B1 (fr) Inhibiteurs de l'integrase du vih
MA31889B1 (fr) N-phenyl -bipyrrolidine-urees substituees et utilisation therapeutique de celles-ci
ECSP089019A (es) Inhibidores de sulfonamida tricíclicos, fusionados del gama secretasa
HN2009001436A (es) Nuevo procedimiento de sintesis de la agometatina
CR9722A (es) Derivados de benzilpiperazina y su uso medico
ECSP088603A (es) Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4

Legal Events

Date Code Title Description
FD Lapse